EmailNurse
23 Sept 2026launched 8 days ago
0.00 ratings
n/aApple doesn’t publish installs
WorldwideSold in 50+ App Store storefronts
1.0latest version · 8 days ago
Screenshots
About
EmailNurse — EmailNurse triages your inbox, summarizes long threads, and drafts polite replies in seconds. • Auto triage: AI sorts mails into Action, FYI, Newsletter, Spam in one tap. • Long-thread summary: 5-line TL;DR with action items extracted. • Reply drafts: polite, professional, or concise — pick a tone. • Template library: save reusable replies for common situations. • Privacy: emails processed on-device first; AI calls only for opted-in tasks. Free Tier: Free tier with daily quota. Try all core features without paying. Pro Subscription: • Higher daily quota • Priority generation lane • Advanced templates • No ads Subscriptions auto-renew until canceled. Manage and cancel via your App Store account settings. Pricing varies by region. Terms of Use (EULA): https://www.apple.com/legal/internet-services/itunes/dev/stdeula/Read more
EmailNurse — EmailNurse triages your inbox, summarizes long threads, and drafts polite replies in seconds.
• Auto triage: AI sorts mails into Action, FYI, Newsletter, Spam in one tap.
• Long-thread summary: 5-line TL;DR with action items extracted.
• Reply drafts: polite, professional, or concise — pick a tone.
• Template library: save reusable replies for common situations.
• Privacy: emails processed on-device first; AI calls only for opted-in tasks.
Free Tier:
Free tier with daily quota.
Try all core features without paying.
Pro Subscription:
• Higher daily quota
• Priority generation lane
• Advanced templates
• No ads
Subscriptions auto-renew until canceled. Manage and cancel via your App Store account settings. Pricing varies by region.
Terms of Use (EULA): https://www.apple.com/legal/internet-services/itunes/dev/stdeula/
Versions
- Version 1.0First seen · 23 Sept 2026
Countries
Worldwide
Apple lists this app in 50 or more storefronts, so it is available almost everywhere.
Turkey
Chart positions
Not seen in the charts we track yet.